Essential thrombocytosis overview: Difference between revisions
(Created page with "{{Essential thrombocytosis}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Hematology [[Category:Oncolog...") |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
'''Essential thrombocytosis''' (ET, also known as essential thrombocythemia) is a rare chronic blood disorder characterized by the [[myeloproliferative syndrome|overproduction]] of [[platelets]] by [[megakaryocyte]]s in the [[bone marrow]] in the absence of an alternative cause. In some cases this disorder may be progressive, and rarely may evolve into [[acute myeloid leukemia]] or [[myelofibrosis]]. It is one of four [[myeloproliferative disorder]]s. | |||
==References== | ==References== | ||
Revision as of 22:01, 20 January 2012
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis overview On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis overview |
|
Risk calculators and risk factors for Essential thrombocytosis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Essential thrombocytosis (ET, also known as essential thrombocythemia) is a rare chronic blood disorder characterized by the overproduction of platelets by megakaryocytes in the bone marrow in the absence of an alternative cause. In some cases this disorder may be progressive, and rarely may evolve into acute myeloid leukemia or myelofibrosis. It is one of four myeloproliferative disorders.